There is a newer version of the record available.

Published April 8, 2020 | Version v1
Dataset Open

Single cell and immune repertoire profiling of COVID-19 patients reveal novel therapeutic candidates

Creators

  • 1. Harbin Institute of Technology

Contributors

Contact person:

  • 1. Harbin Institute of Technology

Description

COVID-19, a novel pneumonia caused by SARS-CoV-2, has rapidly become the largest threat to public health. Recent studies reported lymphocytopenia but also expansions of antigen-specific T/B cells during early-recovery stage. Here we investigated 16 early-recovery patients using scRNA-seq, HLA-genotyping and deep immune repertoire profling. Our analysis revealed 916 COVID-19-specific TCR groups enriched for a novel cytotoxic CD8+ phenotype with both resident memory (ZNF683+) and tissue exit (SIRP5) markers, and identified 114 statistically-confident virus epitopes. Further, we uncovered 374 BCR groups with somatic hypermutations and/or class switch recombinations. Molecular dynamics simulations revealed 15% of the highly expanded groups may serve as neutralizing antibodies against the virus Spike protein. Finally, we discovered that bacterial infection in COVID-19 patients may elevate monocytic myeloidderived suppressor cells via TLR4/NF!B signaling and cause disease aggravation. Together, we expect our findings and immune-receptor datasets to provide immediate therapeutic options against the pandemic of COVID-19.

Files

Files (871.8 MB)

Name Size Download all
md5:770f79723bd09fb7f319144671ffca36
424.3 MB Download
md5:71d7f6aa8bf595688c68f28a981b8a71
418.8 MB Download
md5:3f9e43bab1765cb99e57d3ff0c48881a
28.8 MB Download